| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/03/2008 | WO2008078730A1 Preparation for transnasal application |
| 07/03/2008 | WO2008078725A1 Thiazepine derivative |
| 07/03/2008 | WO2008078674A1 Glucokinase-activating substance |
| 07/03/2008 | WO2008078423A1 Composition containing plant sterol and phosphatidylcholine and process for producing the same |
| 07/03/2008 | WO2008078411A1 Pharmaceutical agent for prevention and/or treatment of inflammatory myopathy |
| 07/03/2008 | WO2008078176A1 Methods, compounds, and compositions for treating metabolic disorders and diabetes |
| 07/03/2008 | WO2008077305A1 Quinoline compounds, intermediates, prepartion methods and uses thereof |
| 07/03/2008 | WO2008077171A1 Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof |
| 07/03/2008 | WO2008052709A3 Monoesters of estrogens with conjugated linoleic acid and uses thereof |
| 07/03/2008 | WO2008051977A3 Methods of reducing phosphate absorption |
| 07/03/2008 | WO2008003484A3 Agent containing chrysin and cholic acid for reducing weight, accelerating lipid catabolism, and/or restricting calories |
| 07/03/2008 | WO2007143434A3 Indazole and isoindole derivatives as glucokinase activating agents |
| 07/03/2008 | WO2007137417A8 Heterocyclic compounds as calcium channel blockers |
| 07/03/2008 | WO2007100652A3 Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 07/03/2008 | US20080161407 Methods for treating metabolic syndrome |
| 07/03/2008 | US20080161398 Stimulation of in vivo production of proteins |
| 07/03/2008 | US20080161395 Derivatives of Aminobutanoic Acid Inhibiting Cpt |
| 07/03/2008 | US20080161380 Amino acid composition |
| 07/03/2008 | US20080161379 Methods of Treating Diabetes Mellitus |
| 07/03/2008 | US20080161374 Pyrazole compounds and uses related thereto |
| 07/03/2008 | US20080161370 Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors |
| 07/03/2008 | US20080161368 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 07/03/2008 | US20080161366 Aminoalkyl substituted aryl sulfamide derivatives and methods of their use |
| 07/03/2008 | US20080161358 Cyanoamide Compounds Useful as Malonyl-COA Decarboxylase Inhibitors |
| 07/03/2008 | US20080161352 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161347 Substituted Aryl and Heteroaryl Derivatives, Compositions Containing Such Compounds and Methods of Use |
| 07/03/2008 | US20080161329 Pharmaceutical uses |
| 07/03/2008 | US20080161326 Novel Sulfone Amide Amide Derivatives |
| 07/03/2008 | US20080161321 Use of Renin Inhibitors in Therapy |
| 07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 07/03/2008 | US20080161308 e.g. 4-[6-(2-cyclohexylethoxy)-3-oxoindan-5-yloxy]butanoic acid; peroxisome proliferator-activated receptor (PPAR) gamma agonist; antiinflammatory, antidiabetic agent; dyslipidaemia, atherosclerosis, insulin resistance |
| 07/03/2008 | US20080161301 2-Oxy-Benzoxazinone Derivatives for the Treatment of Obesity |
| 07/03/2008 | US20080161294 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 07/03/2008 | US20080161279 Methods of Treating Obesity |
| 07/03/2008 | US20080161277 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 07/03/2008 | US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use |
| 07/03/2008 | US20080161247 Synergistic composition for modulating activity of substrate analogs for NAD+, NADP+, NADH or NADPH dependent enzymes and process thereof |
| 07/03/2008 | US20080161243 Chimeric B-type natriuretic peptide (BNP) polypeptide for use in treatment and prevention of cardiovascular disorders |
| 07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/03/2008 | US20080161235 Type 2 diabetes, metabolic syndrome, nonalcoholic fatty liver disease, polycystic ovarian syndrome and obesity; administering an antagonist to said receptor, for example an antibody, short interfering nucleic acid, or a modified sauvagin, corticotropin releasing factor (CRF), or a urocortin |
| 07/03/2008 | US20080161232 C5a Receptor Antagonist |
| 07/03/2008 | US20080160119 Sesquiterpenoid Derivatives Having Adipocyte Differentiation Inhibitory Effect |
| 07/03/2008 | US20080160117 Administering a salt-free fermented soybean paste-like food material, obtained by hydrolyzing soybean and a sub-material with a koji mold |
| 07/03/2008 | US20080160086 Comprising an ingestible matrix within which a calcium source is substantially uniformly and completely dispersed; for preventing bone loss; aid in the uptake and/or metabolism of calcium by the body |
| 07/03/2008 | US20080160075 Pharmaceutical Composition Made From Chinese Traditional Medicine And Method Of Producing Thereof |
| 07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
| 07/03/2008 | US20080160073 preparations of insulin and glucagon; for use when glucagon response to acute hypoglycemia is impaired or lost in patients with advanced Type 1 and Type 2 diabetes |
| 07/03/2008 | US20080160071 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 07/03/2008 | US20080160054 vectors or transgenic organisms; biosynthesis; derived from Physcomitrella |
| 07/03/2008 | US20080160041 C-type lectin specific monoclonal antibody conjugate for use in reducing immune response to specific antigens; immunotherapy; immunosuppression; treating allergies and autoimmune diseases |
| 07/03/2008 | US20080160033 Novel Screening Method |
| 07/03/2008 | US20080160023 Using type-1 peroxisomal targeting signal protein as tool in identifying modulators for prevention and treatment of heart ischemia, dietary obesity, fatty liver disease and hypercholesterolemia |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/03/2008 | US20080159991 Using hormone treatments to prevent and/or treat glucose metabolism disorers |
| 07/03/2008 | US20080159984 Compositions Capable of Facilitating Penetration Across a Biological Barrier |
| 07/03/2008 | CA2674557A1 2-substituted-6-heterocyclic pyrimidone derivatives |
| 07/03/2008 | CA2673921A1 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 07/03/2008 | CA2673657A1 Use of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles |
| 07/03/2008 | CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | CA2673290A1 Methods for treating obesity with a combination comprising a mtp inhibitor and a cholesterol absorption inhibitor |
| 07/03/2008 | CA2673022A1 Methods, compounds, and compositions for treating metabolic disorders and diabetes |
| 07/03/2008 | CA2672088A1 Glucokinase activator |
| 07/03/2008 | CA2671585A1 Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof |
| 07/03/2008 | CA2651942A1 1,2,3,4-tetrahydro-quinoline derivatives as cetp inhibitors |
| 07/02/2008 | EP1939205A1 Tricyclic compound |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1939194A1 Bicyclic aromatic substituted pyridone derivative |
| 07/02/2008 | EP1939192A1 Cyclopentanone derivatives, method of synthesis and uses thereof |
| 07/02/2008 | EP1939189A1 Derivative having ppar agonistic activity |
| 07/02/2008 | EP1939188A1 Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/02/2008 | EP1939174A1 Inclusion complex of ezetimibe and a cyclodextrin and processes in the preparation thereof |
| 07/02/2008 | EP1938838A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 07/02/2008 | EP1938831A1 Novel exendin agonist compounds |
| 07/02/2008 | EP1938830A1 Novel exendin agonist compounds |
| 07/02/2008 | EP1938813A1 Agent for reduction of oxidized albumin level |
| 07/02/2008 | EP1938811A1 Medicinal composition for treating bulimia and depression accompanying bulimia |
| 07/02/2008 | EP1938810A1 Ameliorating agent for metabolic syndrome |
| 07/02/2008 | EP1937716A2 Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function |
| 07/02/2008 | EP1937680A2 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 07/02/2008 | EP1937672A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 07/02/2008 | EP1937668A1 Octahydropentalene-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 07/02/2008 | EP1937663A1 Thiophene derivatives as ppar agonists i |
| 07/02/2008 | EP1937659A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | EP1937658A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | EP1937657A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | EP1937648A1 Diacyl indazol derivatives as lipase and phospholipase inhibitors |
| 07/02/2008 | EP1937647A1 Condensed pyrazole derivatives as ppar agonists ii |
| 07/02/2008 | EP1937646A1 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators |
| 07/02/2008 | EP1937641A2 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 07/02/2008 | EP1937640A2 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 07/02/2008 | EP1937636A1 Processes for the purification of (3r,4s)-4-(4-hydroxy-protected-phenyl)-1-(4-fluorophenyl)-3-(4-fluorophenyl)-3-oxopropyl¨azetidin-2-one |
| 07/02/2008 | EP1937622A1 Compounds for treatment of lipase-mediated diseases |
| 07/02/2008 | EP1937296A2 Compounds for improving nutritional status, cognition and survival |
| 07/02/2008 | EP1937268A2 Indenoisoquinolinone analogs and methods of use thereof |
| 07/02/2008 | EP1937259A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 07/02/2008 | EP1937234A1 Use of choline to prevent thrombosis associated with total parenteral nutrition |
| 07/02/2008 | EP1830841B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |